Cargando…
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
A tumour biomarker is a characteristic that is objectively measured and evaluated in tumour samples as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. The development of a biomarker contemplates distinct phases, including d...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102629/ https://www.ncbi.nlm.nih.gov/pubmed/21504565 http://dx.doi.org/10.1186/1741-7015-9-41 |